Self-injection Device Market Demand Analysis To 2026 Lead By- Becton, Dickinson and Company, Gerresheimer AG, Insulet Corporation

Image result for Self-injection Device

The report presents an in-depth assessment of the Global Self-injection Device including enabling technologies, key trends, market drivers, challenges, standardization, regulatory landscape, deployment models, operator case studies, opportunities, future roadmap, value chain, ecosystem player profiles and strategies. The report also presents forecasts for Global Self-injection Device investments from 2020 till 2025.

Self-Injection devices allow patients with chronic diseases to gain control of their treatment schedule and their treatment setting, thus allowing greater independence and freedom in their social, domestic and professional lives. Self-injection may also offer psychological benefits over administration by healthcare professionals, including improved self-esteem. Removing the need to attend a clinic or hospital for regular injections also brings economic benefits to both the patient and the healthcare system. This economic benefit has been the major growth driving factor for this market. Increasing the prevalence of chronic autoimmune diseases like rheumatoid arthritis and cancer has also helped the growth as self-injections have applications in recovery from these illnesses.

However, stringent regulations for approval from regulatory authorities and lack of awareness of such devices in developing and underdeveloped economies have been restraining the growth of this market.

Click the link to get a free Sample Copy of the Report:

Top Leading Manufactures-

Becton, Dickinson and Company, Gerresheimer AG, Insulet Corporation, Ypsomed AG, Antares Pharma Inc, West Pharmaceutical Services, Consort Medical plc, Sensile Medical AG, Owen Mumford Ltd., SHL Group Auto

Key Market Trends

Pen Injectors are expected to cover a larger market share

Pen injectors are used for the subcutaneous delivery of biopharmaceuticals. Although they are also administered by professionals, these are primarily used for self-administration by the patient. First developed to replace vials and syringes for the treatment of diabetes with insulin, such injection devices have been an important part of the drug-delivery devices for a long time.

According to the 2018 World Health Organization report, the number of people with diabetes has risen from 108 million in 1980 to 422 million in 2014. This has attributed to the rise in the global prevalence of diabetes from 4.7% in 1980 to 8.5% in 2014. Moreover, diabetes prevalence has been rising more rapidly in the middle- and low-income countries. In 2016, an estimated 1.6 million deaths were directly caused by diabetes. Hence, the worldwide increase in diabetes and the growing pressure on health care costs that pushes toward patient self-injection means that their importance is expected to grow further in the future.

North America dominates the market

According to the Center for Disease Control and Prevention (CDC), in 2016, there were an estimated 15.5 million cancer survivors in the United States and this number is expected to increase to 20.3 million by 2026. According to an article by Ji Lin et al. published in Population Health Metrics Journal 2018, the projected number and percent of adults with diagnosed diabetes would increase from 22.3 million (9.1%) in 2014 to 39.7 million (13.9%) in 2030, and to 60.6 million (17.9%) in 2060. Also, the number of people with diabetes aged 65 years or older expected to increase from 9.2 million in 2014 to 21.0 million in 2030, and to 35.2 million in 2060. Hence, with the increasing prevalence of chronic diseases, the demand for self-injection devices, which are used for treatment or recovery from such diseases, is expected to increase.

Inquire for Discount:

What are the market factors that are explained in the report?

Key Strategic Developments: The study also includes the key strategic developments of the market, comprising R&D, new product launch, M&A, agreements, collaborations, partnerships, joint ventures, and regional growth of the leading competitors operating in the market on a Global and regional scale.

Key Market Features: The report evaluated key market features, including revenue, price, capacity, capacity utilization rate, gross, production, production rate, consumption, import/export, supply/demand, cost, market share, CAGR, and gross margin. In addition, the study offers a comprehensive study of the key market dynamics and their latest trends, along with pertinent market segments and sub-segments.

Analytical Tools: Global Self-injection Device Market report includes the accurately studied and assessed data of the key industry players and their scope in the market by means of a number of analytical tools. The analytical tools such as Porter’s five forces analysis, feasibility study, and investment return analysis have been used to analyzed the growth of the key players operating in the market. 

The research includes historic data from 2014 to 2020 and forecasts until 2025 which makes the reports an invaluable resource for industry executives, marketing, sales and product managers, consultants, analysts, and other people looking for key industry data in readily accessible documents with clearly presented tables and graphs.

Media Contact Us:

Irfan Tamboli (Head of Sales) – Market Insights Reports

Phone: + 1704 266 3234 | +91-750-707-8687 |


Leave a Reply

Your email address will not be published. Required fields are marked *